# China NMPA Drug Inspection - Chongqing Kerui Pharmaceutical (Group) Co., Ltd. - Ribavirin tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/chongqing-kerui-pharmaceutical-group-co-ltd/2941a900-93b1-4a35-8eb7-ef0f08645c6c/
Source feed: China

> China NMPA drug inspection for Chongqing Kerui Pharmaceutical (Group) Co., Ltd. published March 20, 2020. Drug: Ribavirin tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Ribavirin tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/chongqing-kerui-pharmaceutical-group-co-ltd/4b065ed6-2aea-4dad-9784-c95d3806c38d/